title: A cost comparison of beta 2-agonist bronchodilators is not a cost-effectiveness comparison.
authors.affiliation: Glaxo Wellcome Inc., Research Triangle Park, North Carolina 27709, USA.
authors.forename: K
authors.initials: K
authors.lastname: Rickard
authors.forename: F
authors.initials: F
authors.lastname: Cox
authors.forename: L
authors.initials: L
authors.lastname: Okamoto
authors.forename: R
authors.initials: R
authors.lastname: Mills
mesh_terms: D000318:Adrenergic beta-Agonists / Q000191:economics* / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy / Q000191:economics*; D017046:Cost Savings; D003362:Cost-Benefit Analysis; D006801:Humans; D017410:Practice Guidelines as Topic / Q000592:standards
chemical_list: D000318:Adrenergic beta-Agonists